Cardiopulmonary Disorders
The term "Cardiopulmonary Disease" describes a range of conditions affecting the heart and lungs. These organs are closely related, and the problem in one can spill over to another. Exposure to tobacco smoke has long been recognized as an important component of cardiovascular risk. Likewise, minimizing your exposure to tobacco smoke is the most effective way to save you from COPD.
Common types of this condition include:
Chronical bronchitis.
Chronic obstructive pulmonary disease (COPD)
Chronic heart failure.
Emphysema.
Cardiopulmonary disease is the medical term used to describe quite number critical problems that affect the heart and lungs. The two-primary tobacco-associated cardiopulmonary illnesses are Cardiovascular Disease (CVD) and Chronic Obstructive Pulmonary Disorder (COPD). Exposure to tobacco smoke has long been diagnosed as a prominent chance component for Cardiovascular Disease. Similarly minimizing exposure to tobacco smoke is the most effective manner to save you COPD. However, the mechanisms by way of which tobacco toxicants increase the danger of Cardiovascular Disease and result in the onset of COPD are nonetheless unclear. Despite discounts in smoking during the last decade, Cardiovascular Disease and COPD stay the first and second main causes of death among smokers. It is important to keep in mind also that for all of us who dies because of smoking as a minimum 30 people live with a critical smoking-associated illness.
The advent of e-cigarettes and other new tobacco products that deliver nicotine as an aerosol in a variety of solvents raises important new questions regarding the potential risk of cardiopulmonary disease among consumers. The use of this new tobacco product has skyrocketed over the past few years, especially among adolescents, and is expected to completely change the traditional cigarette market in the next decade. These new products deliver nicotine and chemical flavoring aerosols based on propylene glycol and / or glycerin by inhalation.
Related Conference of Cardiopulmonary Disorders
14th International Conference on COPD Clinical Trials & Lung Care Advances
6th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
16th International Conference on Pulmonary & Respiratory Medicine
Cardiopulmonary Disorders Conference Speakers
Recommended Sessions
- Airway and Therapeutic Devices
- Asthma and Allergy
- Cardiopulmonary Disorders
- Case Reports in Pulmonology
- Chronic Bronchitis and Respiratory Diseases
- Chronic Obstructive Pulmonary Disease
- Cystic Fibrosis
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Lung Diseases
- Obstructive sleep apnea
- Pediatric Pulmonology and Critical care
- Pulmonary Diseases and therapeutics
- Pulmonary Hypertension
- Pulmonary Rehabilitation
- Respiratory tract Infections
- Sarcoidosis
- Thoracic
- Tuberculosis
Related Journals
Are you interested in
- Advances in Mechanical Ventilation and Respiratory Support - Pulmonology-2026 (Spain)
- Airway Management Techniques in Critical Care Settings - Pulmonology-2026 (Spain)
- Asthma - Pulmonary Meet 2026 (France)
- Asthma Management: Guidelines and Personalized Therapy - Pulmonology-2026 (Spain)
- Cardiopulmonary Disease - Tuberculosis-2026 (France)
- Chronic Bronchitis - Pulmonary Meet 2026 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Pulmonary Meet 2026 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2026 (France)
- Chronic Obstructive Pulmonary Disease (COPD) Updates - Pulmonology-2026 (Spain)
- Climate Change and Respiratory Diseases - Tuberculosis-2026 (France)
- Critical Care Strategies in Sepsis and Multi-Organ Failure - Pulmonology-2026 (Spain)
- Cystic Fibrosis - Pulmonary Meet 2026 (France)
- Drug-Resistant Tuberculosis: - Tuberculosis-2026 (France)
- Early Detection and Diagnosis - Tuberculosis-2026 (France)
- Epidemiology of TB Disease - Tuberculosis-2026 (France)
- Ethical Dilemmas and Decision-Making in ICU Settings - Pulmonology-2026 (Spain)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2026 (France)
- Immunotherapy and Biologics in Respiratory Diseases - Pulmonology-2026 (Spain)
- Infection Control Measures - Tuberculosis-2026 (France)
- Infectious Respiratory Diseases - Pulmonary Meet 2026 (France)
- Innovations in Interventional Pulmonology - Pulmonology-2026 (Spain)
- Integrated Healthcare Approach - Tuberculosis-2026 (France)
- Interstitial Lung Disease (ILD) - Pulmonary Meet 2026 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2026 (France)
- Lung Cancer - Pulmonary Meet 2026 (France)
- Lung Cancer Screening, Diagnosis, and Interventions - Pulmonology-2026 (Spain)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2026 (France)
- Lung Function in Men with and without HIV - Tuberculosis-2026 (France)
- Lung Infection - Tuberculosis-2026 (France)
- Lung Infections: Tuberculosis, Pneumonia, and Beyond - Pulmonology-2026 (Spain)
- Lung Problems - Pulmonary Meet 2026 (France)
- Lung Transplantation - Pulmonary Meet 2026 (France)
- Management of Acute Respiratory Distress Syndrome (ARDS) - Pulmonology-2026 (Spain)
- Multidrug-resistant TB - Tuberculosis-2026 (France)
- Mycobacterial Infections - Tuberculosis-2026 (France)
- Non-Invasive Ventilation in Acute and Chronic Care - Pulmonology-2026 (Spain)
- Nutrition and Tuberculosis - Tuberculosis-2026 (France)
- One Health Approach to TB Control - Tuberculosis-2026 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2026 (France)
- Pediatric Pulmonology and Critical Care Challenges - Pulmonology-2026 (Spain)
- Pediatric Tuberculosis - Tuberculosis-2026 (France)
- Pleural Diseases - Pulmonary Meet 2026 (France)
- Point-of-Care Ultrasound in Critical Care Medicine - Pulmonology-2026 (Spain)
- Post-COVID Pulmonary Complications and Long-Term Care - Pulmonology-2026 (Spain)
- Prevention and Control of Respiratory Diseases - Pulmonary Meet 2026 (France)
- Preventive Therapy - Tuberculosis-2026 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2026 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2026 (France)
- Pulmonary Edema - Tuberculosis-2026 (France)
- Pulmonary Fibrosis and Interstitial Lung Disease - Pulmonology-2026 (Spain)
- Pulmonary Hypertension - Pulmonary Meet 2026 (France)
- Pulmonary Hypertension: Diagnosis and Emerging Therapies - Pulmonology-2026 (Spain)
- Pulmonary Rehabilitation - Pulmonary Meet 2026 (France)
- Pulmonary Rehabilitation and Patient-Centered Recovery - Pulmonology-2026 (Spain)
- Pulmonology - Pulmonary Meet 2026 (France)
- Research and Innovation - Tuberculosis-2026 (France)
- Respiratory Disorders - Pulmonary Meet 2026 (France)
- Respiratory Tract Infections - Pulmonary Meet 2026 (France)
- Role of Imaging in Pulmonary Diagnostics and ICU Care - Pulmonology-2026 (Spain)
- Sleep-Disordered Breathing and CPAP Therapies - Pulmonology-2026 (Spain)
- Sleep-Related Respiratory Disorders - Pulmonary Meet 2026 (France)
- TB Clinical Trials - Tuberculosis-2026 (France)
- TB Vaccines - Tuberculosis-2026 (France)
- TB-HIV Co-Infection: - Tuberculosis-2026 (France)
- TB-HIV Co-infections - Tuberculosis-2026 (France)
- Tuberculosis - Pulmonary Meet 2026 (France)
- Tuberculosis in Vulnerable Populations - Tuberculosis-2026 (France)
- Vaccination Programs: - Tuberculosis-2026 (France)
